FOXF2 and gastric cancer: The FOXM1 transcription factor network is activated in over 84% of cases of high-grade serous ovarian cancers via involvement in the homologous recombination DNA damage and repair pathway9, and FoxC2 has been linked to tumorigenesis and the progression of colorectal cancers through the Akt/GSK-3β/Snail pathway10, while FOXF2 suppresses gastric cancer through a novel FOXF2-IRF2BPL-β-catenin signaling axis11.